Blood, 140(21), 2248-2260. American Society of Hematology Elsawy, M, Chavez, J C, Avivi, I, Larouche, J-F, Wannesson, L, Cwynarski, K, Osman, K, Davison, K, Rudzki, J D, Dahiya, S, Dorritie, K A, Jaglowski, S M, Radford, J, Morschhauser, F, Cunningham, D, Martin Garcia-Sancho, A, Tzachanis, D, Ulrickson, M L, Karmali, R, Kekre, N, Thieblemont, C, Enblad, G, Dreger, P, Malladi, R, Joshi, N, Wang, W-J, Solem, C T, Snider, J T, Cheng, P, To, C & Kersten, M J 2022, ' Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma ', Blood . https://doi.org/10.1182/blood.2022015478